A number of analysts have recently weighed in on the stock. Argus increased their target price on shares of CVS Health to $100.00 and gave the stock a "buy" rating in a report on Tuesday, November 13th. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Seekingalpha.com and their article: "Florida sues Walgreens, CVS over opioid sales - Seeking Alpha" published on November 19, 2018 as well as Benzinga.com's news article titled: "Benzinga's Top Upgrades, Downgrades For November 27, 2018 - Benzinga" with publication date: November 27, 2018. Royal Bank of Canada set a $99.00 target price on shares of CVS Health and gave the stock a "buy" rating in a report on Tuesday, October 23rd.
The 20 analysts offering 12-month price forecasts for CVS Health Corp have a median target of 94.50, with a high estimate of 106.00 and a low estimate of 76.00. Tigress Financial reissued a "buy" rating on shares of CVS Health in a report on Friday, October 26th. They set a "peer perform" rating on the stock. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company's stock. The stock now has an average rating of "Buy" and a consensus price target of $91.15.
CVS Health stock opened at $75.18 on Monday.
The CVS Health Corporation is having a distance of 1.9% form 20 day moving average, SMA 50 of 1.62% and an SMA 200 of 11.52%.CVS Health Corporation a United States of America based Company, belongs to Healthcare sector and Health Care Plans industry. The company has a debt-to-equity ratio of 1.66, a current ratio of 2.44 and a quick ratio of 1.94.
Therefore, the stated figure displays a quarterly performance of 6.11%, bringing six-month performance to 20.47% and year to date performance of 9.66%.As of now, CVS Health Corporation has a P/S, P/E and P/B values of 0.43, 50.86 and 2.21 respectively. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.02. CVS Health had a return on equity of 18.69% and a net margin of 1.65%. The business had revenue of $47.27 billion for the quarter, compared to analysts' expectations of $47.22 billion. During the same period in the previous year, the firm earned $1.50 EPS. The market capitalization of the corporation settled $79.21B whereas it's P/B Ratio was 2.17.
Avión Presidencial saldrá de México este lunes
Una de las promesas del presidente electo, que tomará protesta este sábado, es la venta del avión presidencial . "El lunes el avión partirá del país para ponerse a disposición y ser vendido a donde se va a colocar", dijo.
Aetna shareholders are expected to receive $145.00 in cash and 0.8378 shares of CVS Health common stock. Investors of record on Wednesday, October 24th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.49%. CVS Health's dividend payout ratio (DPR) is now 33.90%. Also, EVP Lisa Bisaccia sold 21,534 shares of CVS Health stock in a transaction on Monday, October 1st. The shares were sold at an average price of $80.00, for a total value of $1,722,720.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
In related news, EVP Eva C. Boratto sold 13,311 shares of CVS Health stock in a transaction on Monday, September 17th. Following the completion of the sale, the executive vice president now directly owns 55,162 shares in the company, valued at approximately $4,256,299.92. Insiders have sold a total of 49,074 shares of company stock worth $3,916,575 in the last quarter. Corporate insiders own 0.53% of the company's stock.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in CVS.
Advisor Partners LLC grew its position in CVS Health Corp (NYSE:CVS) by 8.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The brokerage set an "outperform" rating on the pharmacy operator's stock. Kiley Juergens Wealth Management LLC purchased a new stake in shares of CVS Health during the second quarter worth about $103,000. BlackRock Inc. now owns 74,135,102 shares of the pharmacy operator's stock valued at $4,770,597,000 after buying an additional 4,121,620 shares during the period. Bank of New York Mellon Corp raised its stake in shares of CVS Health by 15.9% in the second quarter. Parnassus Investments CA now owns 16,659,501 shares of the pharmacy operator's stock valued at $1,072,039,000 after acquiring an additional 350,872 shares during the period. BlackRock Inc. grew its position in CVS Health by 5.9% during the second quarter. Finally, Canton Hathaway LLC acquired a new stake in shares of CVS Health in the third quarter valued at approximately $126,000. Veritas Asset Management LLP now owns 11,890,424 shares of the pharmacy operator's stock valued at $765,149,000 after acquiring an additional 508,500 shares during the period. CVS Health Corporation is a part of Healthcare sector and belongs to Health Care Plans industry. It operates through Pharmacy Services and Retail/LTC divisions. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics.